Fisetin — research review 3

...and that’s where Fisetin comes in, as a senolytic flavonol. The idea is it selectively clears out those senescent cells that build up as we age.

Right, and the evidence is quite compelling for its senolytic activity. A study in EBioMedicine in 2018 found Fisetin was the most potent senolytic tested, and when given to mice late in life, it extended both median and maximum lifespan.

It's not just senescent cell clearance either. Fisetin seems to have multiple mechanisms. An article in the International Journal of Molecular Sciences in 2017 showed it restored SIRT1 expression, a protein involved in cell health and longevity.

And that same study also pointed to Fisetin activating the Nrf2 antioxidant pathway, which is crucial for cellular defense against oxidative stress. Plus, there’s evidence from Oncotarget in 2021 suggesting it slightly inhibits the mTOR pathway, echoing some of the gerostatic effects we see with rapamycin.

So, it's a multi-faceted molecule, naturally found in foods like strawberries, apples, persimmons, and onions, according to a 2026 review in Nutrients. But, what about the human evidence?

That's the big unknown, isn't it? We have robust animal data showing reduced age-related pathology and lifespan extension in mice. But translating those exact effects to humans, in terms of dosage, specific pathologies, and long-term safety, is still unproven. We don't yet have large-scale, long-term human trials definitively showing Fisetin extends human lifespan or prevents age-related diseases. That research is still ongoing.